News | News By Subject | News by Disease News By Date | Search News

Alzheimer's Disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Another Alzheimer's Let-Down as FUJIFILM's Candidate Flunks Phase II Test     7/19/2017
Bay Area's E-Scape Bio Bursts Out of Stealth Mode With $63 Million to Tackle Alzheimer's     7/13/2017
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's     6/26/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research     6/21/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin     5/5/2017
Analyzing Wild Optimism and Questionable Studies for Alzheimer’s Drug Development     4/28/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail     4/27/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's     4/26/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B     4/14/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's     3/29/2017
Why This Alzheimer's Biotech May Not Live to See 2020     3/6/2017
Merck & Co. (MRK), Eli Lilly (LLY) Failure Puts Alzheimer's Drug Development Spotlight on Rival Genentech (RHHBY)     3/1/2017
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt     2/20/2017

News from Around the Web
Genentech (RHHBY) R&D Exec Reveals Alzheimer's is Still A Priority     7/19/2017
Blood Test Identifies Key Alzheimer's Marker, Washington University School of Medicine Study Reveals     7/19/2017
In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec     7/18/2017
Your Insomnia Could Actually Lead To Alzheimer’s, Neurology Reveals     7/7/2017
Experts Discover 3 Things That Can Protect The Brain From Alzheimer's, National Academies of Sciences, Engineering, and Medicine Study Reveals     6/26/2017
Alzheimer's Drug Leads UBS To Upgrade Biogen (BIIB)     6/21/2017
Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing, USC Alzheimer's Therapeutic Research Institute (ATRI) Study Reveals     6/16/2017
‘Mini-Me’ Brains-In-A-Dish Mimic Disease, Raise Hope For Eventual Therapies, Nature Reveals     4/27/2017
Why Too Much Sugar Is Bad For Your Brain, Boston University School of Medicine Study Reveals     4/25/2017
Hopes Up On Lasers Kindling Lost Memories In Alzheimer’s Patients, MIT Reveals     3/31/2017
New Test May Predict Onset Of Alzheimer's, UCSF Study Reveals     3/22/2017
How This Biotech Phenom Plans To Speed Up Drug Research And Cure Alzheimer's     3/8/2017
Will BACE Inhibitors Help Alzheimer's Patients?     2/24/2017
Merck & Co. (MRK)'s Alzheimer's Failure Has All Eyes and Hopes Turning to Biogen (BIIB)     2/16/2017
Alzheimer's Causes: Could Refined Sugar Lead To Dementia, Cognitive Decline?     2/14/2017

Press Releases
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference     7/20/2017
Feinstein Institute for Medical Research Release: Alzheimer's Drug Cuts Hallmark Inflammation Related To Metabolic Syndrome By 25 Percent     7/20/2017
Neurotrope (NTRP) Presents Phase II Data Assessing Bryostatin-1 In Moderate-To-Severe Alzheimer's Patients At AAIC 2017     7/19/2017
ProMis Neurosciences Presents At AAIC 2017 Data From Alzheimer's Disease Program     7/19/2017
Cognition Therapeutics Reports Drug-Drug Interaction Results For CT1812, A Disease-Modifying Alzheimer’s Disease Candidate     7/19/2017
Regenacy Pharma Presents Data Demonstrating That HDAC1,2 Inhibition Improved Cognitive Function In Mouse Models Of Alzheimer's Disease At The Alzheimer’s Association International Conference     7/19/2017
Alzheimer's Association Launches $20 Million Lifestyle Intervention Trial In The U.S. To Prevent Cognitive Decline     7/19/2017
EIP Pharma Announces Presentation Of New Mechanism Of Action Data Regarding Neflamapimod (VX-745) At Alzheimer's Association International Conference (AAIC)     7/19/2017
ModGene Pharma Announces Issuance Of U.S. Patent For Alzheimer's Disease Prevention     7/19/2017
EIP Pharma Announces Presentation Of New Positive Clinical Data With Neflamapimod (VX-745) At Alzheimer's Association International Conference (AAIC)     7/18/2017
Alzheimer's Association Release: Can Treating Sleep Problems Lower Dementia Risk?     7/18/2017
AXON Neuroscience's Tau Vaccine Has Completed Phase II Enrolment In Alzheimer's     7/17/2017
Axsome (AXSM) Initiates Phase II/III Trial Of AXS-05 For Alzheimer’s Disease Agitation     7/17/2017
Alzheimer's Association Release: New And Expanded Risk Factors For Cognitive Decline And Alzheimer's Disease     7/17/2017
Alzheimer's Association Release: Stressful Life Experiences Age The Brain By Four Years, African Americans Most At Risk     7/17/2017

//-->